Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Techniclone (TCLN) -- Ignore unavailable to you. Want to Upgrade?

To: t36 who wrote (2828)	1/5/1999 9:23:00 AM
From: shero	Read Replies (1) \| Respond to of 3702

Alot higher than it is today, but alot less than most people think. If Lym-1 is approvable, something I'm beginning to question, it ought to add up to $300MM to TCLN's market cap, or about $3 or $4 a share. If or when Lym gets licensed my questions will be answered. I've always said that if TNT is approvable it can support a Billion dollars to the market cap, or around $10-12. Maybe much more, but I'm not counting on it. I won't give you $0.05 for the other technologies, even though they appear interesting. The reason is VE technology has been around more than 5 years and TCLN doesn't talk about it, or if anyone is interested in it. As for VTA my reasoning goes like this. No presentation from Thorpe in London, and Thorpe is well behind schedule. Peregrine was supposed to have a candidate identified for human testing but I don't think that has been accomplished. I don't know if that means trouble or if it only is a case of a scientist seeking the perfect match rather than go to trials with what they have. Either way its not a good sign. Plus no other statements about additional patents, which, according to the company we would hear about in October. Plus in the middle of his work Thorpe moved from Texas to Maine. I don't know if any or all these things are bad. There maybe perfectly valid explanations. If these other technologies are licensed I'll be happy. But if they're not I won't be disappointed. I've been jilted by this company too many times. So have lots of other people. So to answer your question I'll pick $15, and not this year. But I hope I'm wrong. And for me the only bright spot I feel sure of is TNT 120 day results which shold be released in FEB. Anything more will be a bonus. I wish the company could take steps to end my growing skepticism.